Shenwei Intelligent Medical, protecting health with technological strength
Click a button to chat with our customer service representatives in real time. Whether you're on your lunch break or on your way home from get off work, you can start a conversation anytime and get immediate help without waiting, making communication more efficient.
Digital Therapeutics: Redefining Health Through Technology
What It Is
Digital therapeutics (DTx) are evidence-based interventions delivered through smartphones, wearables, and interactive platforms to help prevent, manage, or treat medical conditions. Unlike traditional drugs or devices, DTx emphasize behavior change and data-driven personalization. For example, SCAMPI improved smoking cessation through a WeChat app; HooHoo Frog enhanced pulmonary rehabilitation adherence for COPD patients via gamified breathing training; and ToothyGuard Adventure guided children toward proper brushing habits. Together, these cases demonstrate the real-world value of DTx in improving health and quality of life.
How It Works
DTx operate through a behavioral science + data monitoring + instant feedback loop. Users engage in health-related tasks (e.g., breathing exercises, brushing challenges), while the system reinforces adherence with animations, rewards, and real-time feedback. At the same time, intelligent algorithms capture symptom reports and wearable data, producing trend analyses and personalized recommendations. This interactive experience boosts patient engagement and generates high-quality real-world evidence for clinicians and researchers, accelerating both trial validation and intervention refinement.
Why Us
Deeplynx brings a multidisciplinary edge to DTx development. With proven success in smoking cessation, respiratory rehabilitation, and pediatric oral health, we have also built an AI-driven development framework, featuring agent support, digital twin simulations, and PROMs-based feedback. Unlike single-point solutions, our approach is systemic, evidence-based, and globally collaborative—designed to scale rapidly across diverse chronic conditions. Our vision is to make clinically validated interventions accessible in everyday life.
What We Will Have in Future
Looking ahead, we will expand our DTx portfolio into mental health (e.g., adolescent depression and anxiety), diabetes management, and sleep apnea (OSA), creating a more holistic digital health ecosystem. In partnership with hospitals, universities, and global collaborators, we will continuously validate and refine these interventions, positioning DTx as a vital tool for chronic disease control and public health governance worldwide. Our vision is simple yet ambitious: enabling everyone to access continuous, personalized, and evidence-based health management—right from their phone or home device.
